Related Experiment Video
Updated: Mar 24, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in
Alexandra M Fajardo1, Debra A MacKenzie1, Sarah L Olguin1
1Department of Pharmaceutical Sciences, University of New Mexico College of Pharmacy, Albuquerque, New Mexico, United States of America.
Abstract:
Tocopherylquinone (TQ), the oxidation product of alpha-tocopherol (AT), is a bioactive molecule with distinct properties from AT. In this study, AT and TQ are investigated for their comparative effects on growth and androgenic activity in prostate cancer cells. TQ potently inhibited the growth of androgen-responsive prostate cancer cell lines (e.g., LAPC4 and LNCaP cells), whereas the growth of androgen-independent prostate cancer cells (e.g., DU145 cells) was not affected by TQ. Due to the growth inhibitory effects induced by TQ on androgen-responsive cells, the anti-androgenic properties of TQ were examined. TQ inhibited the androgen-induced activation of an androgen-responsive reporter and inhibited the release of prostate specific antigen from LNCaP cells. TQ pretreatment was also found to inhibit AR activation as measured using the Multifunctional Androgen Receptor Screening assay. Furthermore, TQ decreased androgen-responsive gene expression, including TM4SF1, KLK2, and PSA over 5-fold, whereas AT did not affect the expression of androgen-responsive genes. Of importance, the antiandrogenic effects of TQ on prostate cancer cells were found to result from androgen receptor protein down-regulation produced by TQ that was not observed with AT treatment. Moreover, none of the androgenic endpoints assessed were affected by AT. The down-regulation of androgen receptor protein by TQ was abrogated by co-treatment with antioxidants. Overall, the biological actions of TQ were found to be distinct from AT, where TQ was found to be a potent inhibitor of cell growth and androgenic activity in androgen-responsive prostate cancer cells.
Insights
Tocopherylquinone (TQ), an alpha-tocopherol oxidation product, potently inhibits prostate cancer cell growth and androgenic activity by down-regulating androgen receptors. Alpha-tocopherol (AT) showed no such effects, highlighting TQ's distinct therapeutic potential.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Alpha-tocopherol (AT) is a form of vitamin E with known biological functions.
- Tocopherylquinone (TQ) is an oxidation product of AT with distinct properties.
- Prostate cancer growth is often driven by androgen receptor (AR) signaling.
Purpose of the Study:
- To compare the effects of AT and TQ on prostate cancer cell growth and androgenic activity.
- To investigate the anti-androgenic mechanisms of TQ.
- To determine if TQ's effects are distinct from AT.
Main Methods:
- Cell culture of androgen-responsive (LAPC4, LNCaP) and androgen-independent (DU145) prostate cancer lines.
- Reporter assays to measure androgen-induced activation.
- Prostate-specific antigen (PSA) release assays.
- Multifunctional Androgen Receptor Screening assay.
- Quantitative gene expression analysis.
- Western blotting for AR protein levels.
- Antioxidant co-treatment experiments.
Main Results:
- TQ significantly inhibited growth in androgen-responsive prostate cancer cells, but not androgen-independent cells.
- TQ demonstrated potent anti-androgenic activity, inhibiting AR activation and PSA release.
- TQ decreased expression of androgen-responsive genes (TM4SF1, KLK2, PSA) over 5-fold.
- TQ down-regulated androgen receptor protein levels, an effect not seen with AT.
- Antioxidants abrogated TQ-induced AR protein down-regulation.
- AT did not affect androgenic endpoints or gene expression.
Conclusions:
- Tocopherylquinone (TQ) exhibits distinct biological actions compared to alpha-tocopherol (AT).
- TQ is a potent inhibitor of cell growth and androgenic activity in androgen-responsive prostate cancer.
- TQ's anti-androgenic effects are mediated by the down-regulation of androgen receptor protein.
More Related Videos
Related Concept Videos
Radical Autoxidation
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Bioactivation and Tissue Toxicity
Oxidation of Phenols to Quinones
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...

